Stryker Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
January 31, 2023 at 09:05 pm
Share
Stryker Corporation reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was USD 5,202 million compared to USD 4,701 million a year ago. Net income was USD 563 million compared to USD 662 million a year ago. Basic earnings per share from continuing operations was USD 1.48 compared to USD 1.75 a year ago. Diluted earnings per share from continuing operations was USD 1.47 compared to USD 1.73 a year ago.
For the full year, sales was USD 18,449 million compared to USD 17,108 million a year ago. Net income was USD 2,358 million compared to USD 1,994 million a year ago. Basic earnings per share from continuing operations was USD 6.23 compared to USD 5.29 a year ago. Diluted earnings per share from continuing operations was USD 6.17 compared to USD 5.21 a year ago.
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
STRYKER CORPORATION 
